Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
0.3400
+0.0303 (9.78%)
At close: Apr 2, 2025, 4:00 PM
0.3570
+0.0170 (5.00%)
After-hours: Apr 2, 2025, 7:46 PM EDT

Ovid Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-26.43-52.34-54.17122.83-81.04
Upgrade
Depreciation & Amortization
0.610.571.380.240.31
Upgrade
Asset Writedown & Restructuring Costs
---7.3-
Upgrade
Loss (Gain) From Sale of Investments
-3.35-20.45--
Upgrade
Stock-Based Compensation
6.287.296.565.057.53
Upgrade
Other Operating Activities
-32.91-1.68-1.22--0.2
Upgrade
Change in Accounts Payable
-0.511.75-5.171.72.33
Upgrade
Change in Unearned Revenue
----12.3812.38
Upgrade
Change in Other Net Operating Assets
0.360.64-3.06-6.137.1
Upgrade
Operating Cash Flow
-55.96-45.78-55.23118.61-51.58
Upgrade
Capital Expenditures
-0.07-0.04-1.22-0.18-0.13
Upgrade
Sale (Purchase) of Intangibles
-0.09-0.1-0.19-0.01-0.26
Upgrade
Investment in Securities
54.75-2.44-85.46-1.6335.04
Upgrade
Other Investing Activities
0-0-1--
Upgrade
Investing Cash Flow
54.59-2.58-87.88-1.8234.65
Upgrade
Issuance of Common Stock
0.620.540.180.9347.24
Upgrade
Other Financing Activities
-30--0.02-0.16
Upgrade
Financing Cash Flow
0.6230.540.180.947.07
Upgrade
Miscellaneous Cash Flow Adjustments
-0---
Upgrade
Net Cash Flow
-0.74-17.83-142.93117.6930.14
Upgrade
Free Cash Flow
-56.03-45.82-56.45118.43-51.71
Upgrade
Free Cash Flow Margin
-9898.76%-11689.03%-3756.55%56.83%-409.85%
Upgrade
Free Cash Flow Per Share
-0.79-0.65-0.801.74-0.89
Upgrade
Levered Free Cash Flow
-29.9-25.89-36.2475.6-31.66
Upgrade
Unlevered Free Cash Flow
-29.9-25.89-36.2475.6-31.66
Upgrade
Change in Net Working Capital
0.14-2.388.047.14-11.79
Upgrade
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q